• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肿瘤衍生膜泡：个性化免疫治疗的有前景工具。

Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.

作者信息

Xu Jiabin, Cao Wenqiang, Wang Penglai, Liu Hong

机构信息

School of Stomatology, Xuzhou Medical University, Xuzhou 221004, China.

Affiliated Stomatological Hospital of Xuzhou Medical University, Xuzhou 221004, China.

出版信息

Pharmaceuticals (Basel). 2022 Jul 16;15(7):876. doi: 10.3390/ph15070876.

DOI:10.3390/ph15070876
PMID:35890175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318328/
Abstract

Tumor-derived membrane vesicles (TDMVs) are non-invasive, chemotactic, easily obtained characteristics and contain various tumor-borne substances, such as nucleic acid and proteins. The unique properties of tumor cells and membranes make them widely used in drug loading, membrane fusion and vaccines. In particular, personalized vectors prepared using the editable properties of cells can help in the design of personalized vaccines. This review focuses on recent research on TDMV technology and its application in personalized immunotherapy. We elucidate the strengths and challenges of TDMVs to promote their application from theory to clinical practice.

摘要

肿瘤衍生膜泡（TDMVs）具有非侵入性、趋化性、易于获取等特点，且含有多种肿瘤源性物质，如核酸和蛋白质。肿瘤细胞及膜的独特性质使其在药物装载、膜融合和疫苗方面得到广泛应用。特别是利用细胞的可编辑特性制备的个性化载体有助于个性化疫苗的设计。本综述聚焦于TDMV技术的最新研究及其在个性化免疫治疗中的应用。我们阐明了TDMVs的优势与挑战，以推动其从理论到临床实践的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/4696dcd57e29/pharmaceuticals-15-00876-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/2626368123a7/pharmaceuticals-15-00876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/70a286b063a9/pharmaceuticals-15-00876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/af613db8765b/pharmaceuticals-15-00876-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/e5ccb3e09688/pharmaceuticals-15-00876-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/b89bebb5e452/pharmaceuticals-15-00876-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/3e2d77e27540/pharmaceuticals-15-00876-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/4696dcd57e29/pharmaceuticals-15-00876-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/2626368123a7/pharmaceuticals-15-00876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/70a286b063a9/pharmaceuticals-15-00876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/af613db8765b/pharmaceuticals-15-00876-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/e5ccb3e09688/pharmaceuticals-15-00876-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/b89bebb5e452/pharmaceuticals-15-00876-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/3e2d77e27540/pharmaceuticals-15-00876-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0930/9318328/4696dcd57e29/pharmaceuticals-15-00876-g007.jpg

相似文献

1
Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.肿瘤衍生膜泡：个性化免疫治疗的有前景工具。
Pharmaceuticals (Basel). 2022 Jul 16;15(7):876. doi: 10.3390/ph15070876.
2
Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy.外科肿瘤衍生的个性化光热疫苗制剂用于癌症免疫治疗。
ACS Nano. 2019 Mar 26;13(3):2956-2968. doi: 10.1021/acsnano.8b07371. Epub 2019 Mar 4.
3
Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications.基于磷脂膜的纳米囊泡作为肿瘤免疫治疗疫苗：分类、机制与应用
Pharmaceutics. 2022 Nov 11;14(11):2446. doi: 10.3390/pharmaceutics14112446.
4
Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy.用于癌症免疫治疗的细胞膜衍生囊泡
Pharmaceutics. 2023 Dec 22;16(1):22. doi: 10.3390/pharmaceutics16010022.
5
PAI/MRI Visualization of Tumor Derived Cellular Microvesicles with Endogenous Biopolymer Nanoparticles Modification.肿瘤衍生细胞微囊泡的 PAI/MRI 可视化，具有内源性生物聚合物纳米颗粒修饰。
Int J Nanomedicine. 2022 Jun 30;17:2883-2890. doi: 10.2147/IJN.S367721. eCollection 2022.
6
Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy.基于自体肿瘤细胞膜和细菌外膜的杂交囊泡增强固有免疫反应和个性化肿瘤免疫治疗。
Nano Lett. 2021 Oct 27;21(20):8609-8618. doi: 10.1021/acs.nanolett.1c02482. Epub 2021 Oct 18.
7
Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy.工程化细菌膜囊泡是疫苗设计和肿瘤免疫治疗中很有前景的载体。
Adv Drug Deliv Rev. 2022 Jul;186:114321. doi: 10.1016/j.addr.2022.114321. Epub 2022 May 6.
8
Phytochemical Engineered Bacterial Outer Membrane Vesicles for Photodynamic Effects Promoted Immunotherapy.基于植物化学工程的细菌外膜囊泡用于促进光动力免疫治疗的效果。
Nano Lett. 2022 Jun 8;22(11):4491-4500. doi: 10.1021/acs.nanolett.2c01280. Epub 2022 May 23.
9
Towards customized cancer vaccines: a promising filed in personalized cancer medicine.迈向定制化癌症疫苗：个性化癌症医学的充满希望的领域。
Expert Rev Vaccines. 2021 May;20(5):545-557. doi: 10.1080/14760584.2021.1909479. Epub 2021 Apr 5.
10
Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer Immunotherapy.赋予癌细胞膜囊泡功能性 DNA 作为癌症免疫治疗的靶向疫苗。
Nano Lett. 2021 Nov 24;21(22):9410-9418. doi: 10.1021/acs.nanolett.1c02582. Epub 2021 Nov 3.

引用本文的文献

1
The role of exosomes in bladder cancer immunotherapy.外泌体在膀胱癌免疫治疗中的作用。
J Natl Cancer Cent. 2025 May 2;5(3):252-266. doi: 10.1016/j.jncc.2025.04.001. eCollection 2025 Jun.
2
GelMA microneedle-loaded bio-derived nanovaccine shows therapeutic potential for gliomas.载有明胶甲基丙烯酰基（GelMA）微针的生物衍生纳米疫苗对神经胶质瘤显示出治疗潜力。
Sci Technol Adv Mater. 2024 Nov 7;25(1):2426444. doi: 10.1080/14686996.2024.2426444. eCollection 2024.
3
Cancer biotherapy: review and prospect.癌症生物疗法：综述与展望。

本文引用的文献

1
A vaccine targeting resistant tumours by dual T cell plus NK cell attack.一种通过双重 T 细胞加自然杀伤细胞攻击来靶向耐药肿瘤的疫苗。
Nature. 2022 Jun;606(7916):992-998. doi: 10.1038/s41586-022-04772-4. Epub 2022 May 25.
2
Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy.用于癌症免疫治疗的递送癌细胞膜包被纳米颗粒的可溶解微针
RSC Adv. 2021 Mar 11;11(17):10393-10399. doi: 10.1039/d1ra00747e. eCollection 2021 Mar 5.
3
Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy.
Clin Exp Med. 2024 May 27;24(1):114. doi: 10.1007/s10238-024-01376-2.
4
Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment.用于化疗-光热-免疫联合癌症治疗的肿瘤源性细胞外囊泡给药系统
iScience. 2024 Jan 8;27(2):108833. doi: 10.1016/j.isci.2024.108833. eCollection 2024 Feb 16.
5
CCR7 Mediated Mimetic Dendritic Cell Vaccine Homing in Lymph Node for Head and Neck Squamous Cell Carcinoma Therapy.CCR7 介导的模拟树突状细胞疫苗归巢于颈部淋巴结用于头颈部鳞状细胞癌治疗。
Adv Sci (Weinh). 2023 Jun;10(17):e2207017. doi: 10.1002/advs.202207017. Epub 2023 Apr 24.
6
Exosomes: A potential tool for immunotherapy of ovarian cancer.外泌体：卵巢癌免疫治疗的潜在工具。
Front Immunol. 2023 Jan 18;13:1089410. doi: 10.3389/fimmu.2022.1089410. eCollection 2022.
仿生纳米颗粒直接重塑免疫抑制微环境以增强胶质母细胞瘤免疫治疗。
Bioact Mater. 2022 Jan 5;16:418-432. doi: 10.1016/j.bioactmat.2021.12.029. eCollection 2022 Oct.
4
Transfer of photothermal nanoparticles using stem cell derived small extracellular vesicles for in vivo treatment of primary and multinodular tumours.利用干细胞衍生的小细胞外囊泡传递光热纳米颗粒，用于治疗原发性和多结节肿瘤的体内治疗。
J Extracell Vesicles. 2022 Mar;11(3):e12193. doi: 10.1002/jev2.12193.
5
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer.树突状细胞/肿瘤细胞融合细胞膜纳米疫苗的研制及其在卵巢癌治疗中的应用。
Front Immunol. 2022 Feb 17;13:828263. doi: 10.3389/fimmu.2022.828263. eCollection 2022.
6
Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.杂交细胞膜功能化仿生纳米粒子用于骨肉瘤的靶向治疗。
Int J Nanomedicine. 2022 Feb 22;17:837-854. doi: 10.2147/IJN.S346685. eCollection 2022.
7
Recent advances in biomaterial-boosted adoptive cell therapy.生物材料增强过继细胞疗法的最新进展。
Chem Soc Rev. 2022 Mar 7;51(5):1766-1794. doi: 10.1039/d1cs00786f.
8
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.工程化外泌体作为原位 DC 致敏疫苗增强乳腺癌的抗肿瘤免疫。
Mol Cancer. 2022 Feb 11;21(1):45. doi: 10.1186/s12943-022-01515-x.
9
Inhibition of tumor recurrence and metastasis a surgical tumor-derived personalized hydrogel vaccine.抑制肿瘤复发和转移的一种外科肿瘤衍生的个性化水凝胶疫苗。
Biomater Sci. 2022 Mar 2;10(5):1352-1363. doi: 10.1039/d1bm01596f.
10
Decade-long leukaemia remissions with persistence of CD4 CAR T cells.长达十年的白血病缓解期与 CD4 CAR T 细胞的持续存在。
Nature. 2022 Feb;602(7897):503-509. doi: 10.1038/s41586-021-04390-6. Epub 2022 Feb 2.